Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilbert H Mason

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Pediatrics|June 20, 2002
Prevalence of superantigen-secreting bacteria in patients with Kawasaki diseaseDonald Y M Leung, H Cody Meissner, Stanford T Shulman, et al.
The Journal of Pediatrics|May 5, 2005
Infliximab treatment for refractory Kawasaki syndromeJane C Burns, Wilbert H Mason, Sarmistha B Hauger, et al.
The Pediatric Infectious Disease Journal|July 25, 2017
An Observational Study of Severe Pertussis in 100 Infants ≤120 Days of AgeJames D Cherry, Kristen Wendorf, Brooke Bregman, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Pediatrics|June 20, 2002
Prevalence of superantigen-secreting bacteria in patients with Kawasaki diseaseDonald Y M Leung, H Cody Meissner, Stanford T Shulman, et al.
The Journal of Pediatrics|May 5, 2005
Infliximab treatment for refractory Kawasaki syndromeJane C Burns, Wilbert H Mason, Sarmistha B Hauger, et al.
The Pediatric Infectious Disease Journal|July 25, 2017
An Observational Study of Severe Pertussis in 100 Infants ≤120 Days of AgeJames D Cherry, Kristen Wendorf, Brooke Bregman, et al.
Pageof 2